HK Business Breakthrough Drives Nearly 5% Intraday Rally for CARSGEN-B

Deep News

Sep 11

CARSGEN-B (02171) saw its share price climb nearly 5% during intraday trading, building on optimistic market sentiment. As of the latest update, shares were up 1.84%, trading at HKD 12.70 with a turnover of HKD 20.64 million.

The company announced a significant advancement in its advanced therapy product operations in Hong Kong, having secured the necessary licensing qualifications for wholesale supply and distribution of related pharmaceutical products. This achievement marks a crucial milestone in CARSGEN-B's international expansion strategy for Karma (sugraucilene autoleucel injection), paving the way for exploring patient access pathways and related business development in the territory.

Beyond Hong Kong, this development serves as a vital stepping stone for CARSGEN-B's broader overseas growth plans. The company intends to continue advancing Karma's global footprint, actively exploring market access and patient reachability in Hong Kong and other international markets while strengthening collaboration with local medical institutions and partners. The overarching goal remains delivering innovative cell therapies to a wider base of patients worldwide.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/news/1195415295"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1195415295\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1195415295?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-11 10:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1195415295","market":"sh","top_or_hot":-1,"title":"HK Business Breakthrough Drives Nearly 5% Intraday Rally for CARSGEN-B","media":"Deep News","content":"<p><b>CARSGEN-B</b> (02171) saw its share price climb nearly 5% during intraday trading, building on optimistic market sentiment. As of the latest update, shares were up 1.84%, trading at HKD 12.70 with a turnover of HKD 20.64 million.<br><br>The company announced a significant advancement in its advanced therapy product operations in Hong Kong, having secured the necessary licensing qualifications for wholesale supply and distribution of related pharmaceutical products. This achievement marks a crucial milestone in <b>CARSGEN-B</b>'s international expansion strategy for Karma (sugraucilene autoleucel injection), paving the way for exploring patient access pathways and related business development in the territory.<br><br>Beyond Hong Kong, this development serves as a vital stepping stone for <b>CARSGEN-B</b>'s broader overseas growth plans. The company intends to continue advancing Karma's global footprint, actively exploring market access and patient reachability in Hong Kong and other international markets while strengthening collaboration with local medical institutions and partners. The overarching goal remains delivering innovative cell therapies to a wider base of patients worldwide.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HK Business Breakthrough Drives Nearly 5% Intraday Rally for CARSGEN-B</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHK Business Breakthrough Drives Nearly 5% Intraday Rally for CARSGEN-B\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-09-11 10:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>CARSGEN-B</b> (02171) saw its share price climb nearly 5% during intraday trading, building on optimistic market sentiment. As of the latest update, shares were up 1.84%, trading at HKD 12.70 with a turnover of HKD 20.64 million.<br><br>The company announced a significant advancement in its advanced therapy product operations in Hong Kong, having secured the necessary licensing qualifications for wholesale supply and distribution of related pharmaceutical products. This achievement marks a crucial milestone in <b>CARSGEN-B</b>'s international expansion strategy for Karma (sugraucilene autoleucel injection), paving the way for exploring patient access pathways and related business development in the territory.<br><br>Beyond Hong Kong, this development serves as a vital stepping stone for <b>CARSGEN-B</b>'s broader overseas growth plans. The company intends to continue advancing Karma's global footprint, actively exploring market access and patient reachability in Hong Kong and other international markets while strengthening collaboration with local medical institutions and partners. The overarching goal remains delivering innovative cell therapies to a wider base of patients worldwide.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1574","symbol_name":"生物医药B类股","start_time":0,"source_url":"","article_id":"1195415295","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1195415295","pubTimestamp":1789095018,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"CARSGEN-B (02171) saw its share price climb nearly 5% during intraday trading, building on optimistic market sentiment. As of the latest update, shares were up 1.84%, trading at HKD 12.70 with a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1574":"生物医药B类股","BK1585":"昨日强势股","BK1587":"次新股","02171":"科济药业-B","BK1161":"生物科技"},"translate_title":"香港业务突破推动 CARSGEN-B 盘中上涨近 5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02171":1},"content_text":"CARSGEN-B (02171) saw its share price climb nearly 5% during intraday trading, building on optimistic market sentiment. As of the latest update, shares were up 1.84%, trading at HKD 12.70 with a turnover of HKD 20.64 million.The company announced a significant advancement in its advanced therapy product operations in Hong Kong, having secured the necessary licensing qualifications for wholesale supply and distribution of related pharmaceutical products. This achievement marks a crucial milestone in CARSGEN-B's international expansion strategy for Karma (sugraucilene autoleucel injection), paving the way for exploring patient access pathways and related business development in the territory.Beyond Hong Kong, this development serves as a vital stepping stone for CARSGEN-B's broader overseas growth plans. The company intends to continue advancing Karma's global footprint, actively exploring market access and patient reachability in Hong Kong and other international markets while strengthening collaboration with local medical institutions and partners. The overarching goal remains delivering innovative cell therapies to a wider base of patients worldwide.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}